Myo Inositol: Common Difficulties Encountered by Buyers During Procurement & HiSiaddi’s Solutions

As a new foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply raw materials of Myo Inositol from multiple well-known original manufacturers. As a technology R&D-oriented foreign trade service provider, HiSiaddi will professionally sort out common difficulties faced by B-end buyers purchasing Myo Inositol in China and propose targeted solutions from HiSiaddi.

If you require more professional and in-depth analysis on Myo Inositol procurement, please contact HiSiaddi customer service.

I. High-End European & American Dietary Supplement & Pharmaceutical Raw Material Enterprises (Reproductive Health Supplements, Metabolic Regulation Tablets, Medical Nutritional Preparations, High-End Oral Liquids)

(I) Core Pain Points: Substandard Chiral Purity, Unbalanced Isomers, Excessive Solvent/Heavy Metals, Reduced Efficacy & High Compliance Risks

1.

Low D-chiro purity and mixed inositol isomers drastically attenuate core efficacy High-end European and American pharmaceutical and health supplements explicitly require D-chiro-Inositol purity ≥99% with strict control over co-existing isomers such as Myo-Inositol. Low-purity raw materials with excessive isomers disrupt human metabolic regulation mechanisms, reducing core efficacy for PCOS, blood glucose regulation and endocrine conditioning by over 40%. Finished end products deliver poor clinical feedback and sharply lower repeat purchase rates.

2.

3.

Fluctuating optical rotation leads to inconsistent batch efficacy and failure to pass pharmacopoeia testing Optical rotation serves as the core indicator for judging chiral structure; deviations from standard ranges indicate damaged chiral structures. After being processed into tablets and oral liquids, products of different batches exhibit inconsistent active potency, failing to meet USP and EP Pharmacopoeia standards and preventing formal shelf sales.

4.

5.

Excessive organic solvent residues trigger FDA sampling warnings and product recalls Residual solvents including methanol, ethanol and ethyl acetate generated during purification face strict limit standards for European and American food and pharmaceutical raw materials. Excessive residues not only produce irritating odors but also pose long-term intake safety hazards. Detection during random sampling will directly result in cargo detention and full-batch recalls, causing severe brand losses.

6.

7.

High moisture and ash content lead to tablet sticking, prolonged disintegration and turbidity/precipitation in oral liquids Moisture content exceeding 0.4% causes powder moisture absorption, resulting in sticking and splitting during tableting; excessive ash generates suspended matter and turbidity in oral liquids and nutrient solutions after long-term storage, failing appearance and physical-chemical indicators. Inorganic impurities also slow tablet disintegration, violating pharmaceutical production specifications.

8.

9.

Excessive microorganisms create hygiene safety hazards for pharmaceutical and oral preparations Medical and high-end oral products impose zero tolerance for total bacterial count, mold, yeast and pathogenic bacteria. Ordinary raw materials easily absorb moisture during storage and transportation, breeding microorganisms and rendering finished products unqualified upon inspection and prohibited from circulation.

10.

11.

Poor thermal stability leads to active ingredient degradation during high-temperature granulation and sterilization Raw materials with insufficient heat resistance experience gradual decomposition of active ingredients during wet granulation and high-temperature oral liquid sterilization, resulting in finished product active content lower than labeled values and violations of European and American labeling regulations.

12.

(II) Targeted Solutions

1.

Chiral separation + multi-stage recrystallization technology delivers stable D-chiro purity ≥99.2% with tightly controlled isomers Exclusive chiral separation technology combined with low-temperature recrystallization stabilizes D-chiro-Inositol purity above 99.2% and limits co-existing isomer content within 0.3%, guaranteeing core efficacy for metabolic and endocrine regulation and adapting to high-end health product formulations.

2.

3.

Closed-loop process strictly controls optical rotation with minimal batch differences for smooth pharmacopoeia compliance Full-process online monitoring of optical rotation indicators ensures stable values within standard ranges and intact chiral structures, delivering uniform finished product efficacy fully compliant with USP and EP Pharmacopoeia requirements.

4.

5.

High-temperature vacuum desolvation + multi-stage water washing reduce solvent residues far below international limits Additional negative-pressure solvent removal procedures paired with deep pure water rinsing control all organic solvent residues below 50% of regulatory limits with zero foreign odors, eliminating risks of FDA and customs sampling penalties.

6.

7.

Low-temperature vacuum drying + high-purity purification stabilize moisture ≤0.3% and ash ≤0.1% for compatible pharmaceutical production Vacuum low-temperature drying maintains moisture stably below 0.3%, while high-temperature ash removal reduces inorganic impurities. The resulting dry, loose powder avoids tableting sticking and meets tablet disintegration standards; oral liquid systems remain clear without precipitation.

8.

9.

Production in Class 10,000 sterile workshops + vacuum moisture-proof sealed packaging ensures full compliance with microbial indicators Full-process aseptic production and packaging paired with vacuum moisture-proof sealed packaging isolate external microbial contamination, with total bacterial count, pathogenic bacteria and other indicators fully meeting pharmaceutical and food grade standards.

10.

11.

Compound food-grade heat stabilizers deliver high-temperature processing resistance with negligible active ingredient degradation Optimized raw material crystal structures paired with compliant thermal stabilizers restrict active ingredient degradation below 2% under short-term 100℃ sterilization and granulation conditions, aligning finished product content with labeled values.

12.

II. European & American Functional Food & Beverage Enterprises (Solid Instant Powders, Functional Drinks, Meal Replacements, Gel Soft Candies)

(I) Core Pain Points: Poor Solubility, Weak Powder Flowability, Residual Odorous Impurities, Production Disruptions & Inferior Finished Product Appearance/Taste

1.

Insufficient cold water solubility causes crystal precipitation after low-temperature refrigeration of beverages Conventional D-chiro-Inositol powder dissolves slowly in cold water and easily precipitates white crystals in bottled functional drinks and refrigerated instant powders under low temperatures, damaging product appearance and drinking experience and increasing end-user complaints.

2.

3.

Poor powder flowability leads to bridging and uneven feeding in fully automatic batching systems Most food production lines adopt loss-in-weight automatic batching machines; raw material powder prone to agglomeration with weak flowability frequently causes bridging and material shortage in silos, generating large deviations in raw material addition ratios across batches and unstable finished product active ingredient content.

4.

5.

Trace impurities produce foreign odors that mask original food flavors Trace impurities remaining from purification generate faint bitter and chemical odors, masking the inherent flavors of soft candies, tea beverages and meal replacements and reducing consumer acceptance.

6.

7.

Uneven particle size distribution creates grainy texture in soft candies and instant drinks Large disparities in particle thickness prevent complete mixing, leaving white granular spots inside soft candies and noticeable gritty residue in instant beverages, resulting in rough taste that fails to meet high-end food quality standards.

8.

9.

Weak moisture resistance causes rapid caking during open feeding and warehousing Production workshops experience fluctuating air circulation and humidity; raw materials quickly absorb moisture and cake after opening, hindering feeding operations. Crushing caked materials also leads to localized uneven ingredient distribution and increased production losses.

10.

(II) Targeted Solutions

1.

Ultra-fine grinding + surface modification enables rapid dissolution in cold and hot water with no precipitation after refrigeration Powder undergoes ultra-fine crushing followed by water-solubility modification for fast cold water dissolution without crystalline precipitation after 72 hours of refrigeration at -5℃, compatible with all liquid beverage production categories.

2.

3.

Powder flow modification ensures smooth silo feeding and precise batching measurement Compliant food-grade flow additives are incorporated to maintain loose, non-agglomerated powder with zero silo bridging or material shortage in automatic batching systems, controlling batching errors within ±1% and delivering uniform and stable finished product composition.

4.

5.

Activated carbon adsorption + low-temperature deodorization delivers pure odor-free material compatible with all food formulations Food-grade activated carbon adsorbs impurities paired with low-temperature vacuum deodorization to completely eliminate bitter and residual chemical odors without interfering with the original flavors of soft candies, tea beverages and meal replacements.

6.

7.

Jet milling + precision grading delivers uniform fine particle size for smooth, grain-free mouthfeel Particle size intervals are controlled via grading to achieve consistent particle dimensions and thorough mixing, creating soft, uniform finished soft candies and instant beverages free of white spots and gritty texture.

8.

9.

Moisture-proof coating technology + moisture-resistant packaging delivers long-term anti-caking performance after opening Food-grade moisture-proof coating is applied to powder surfaces paired with composite moisture-proof bag packaging, preventing moisture absorption and caking during open use under conventional workshop humidity levels.

10.

III. Japanese & South Korean Oral Beauty & Maternal-Infant Nutrition Enterprises (Oral Beauty Liquids, Prenatal & Postnatal Nutritional Powders, High-End Dietary Granules)

(I) Core Pain Points: Excessive Heavy Metals, Missing Organic/Exclusive Certifications, Fluctuating Purity & Failure to Meet Market Access Thresholds

1.

Elevated heavy metal (lead, arsenic, cadmium) content fails Japanese and South Korean oral food and beauty product access standards Japan and South Korea enforce extremely strict heavy metal limits for oral raw materials; ordinary raw materials often approach critical threshold values, failing inspection and blocking entry into mainstream channels including drugstores and maternal-infant retail stores.

2.

3.

Lack of organic and functional certifications prevents labeling of selling points and reduces product premium capacity The Japanese and South Korean markets prioritize organic and functional certifications; products without organic JAS and local functional filing certifications cannot market natural or functional selling points, forcing low-price circulation with slim profit margins.

4.

5.

Fluctuating batch purity destabilizes efficacy of maternal-infant nutritional products and damages brand reputation Maternal and prenatal products demand extremely consistent raw material quality; purity fluctuations cause inconsistent nutritional supplementation efficacy, triggering end-user doubts and harming brand credibility.

6.

7.

Insufficient water solubility and transparency create haze and stratification in oral beauty liquids Oral beauty liquids require crystal-clear aqueous solutions; raw materials easily generate slight haze and static stratification after dissolution, directly resulting in full-batch scrapping due to unqualified appearance.

8.

(II) Targeted Solutions

1.

Specialized chelation heavy metal removal process delivers indicators far below Japanese and South Korean regulatory limits A dedicated heavy metal chelation filtration step is added during production to control lead, arsenic, cadmium and other metals below 40% of regulatory limits for seamless passage through official Japanese and South Korean sampling inspections.

2.

3.

Assistance with regional exclusive certification processing and complete localized compliance documents Support processing of organic JAS, local food functional filings and other certifications with full sets of localized test reports and qualification documents to enable labeled selling points and boost premium profit margins.

4.

5.

Full-process automated production limits batch purity fluctuations ≤0.5% for highly consistent quality Automated synthesis, purification and packaging production lines feature full online monitoring of core indicators with minimal purity differences across batches, delivering stable quality for maternal and prenatal nutritional products.

6.

7.

Advanced refining optimizes dissolution transparency for clear, non-stratified oral liquids Insoluble impurities are deeply removed to produce highly transparent aqueous solutions with zero haze or stratification after long-term static storage, meeting appearance requirements of high-end oral beauty products.

8.

IV. Indian, Southeast Asian Mass-Market Food & Ordinary Health Supplement Processing Plants (Mass Functional Powders, Standard Nutritional Tablets, Animal Feed Additives, Cost-Oriented)

(I) Core Pain Points: Widespread Adulteration, Chaotic Indicators, Deterioration Under High Temperature & Humidity, Missing Compliance Documents, High Production Costs & Frequent Customer Complaints

1.

Low-price raw materials adulterated with glucose and starch drastically reduce active ingredient content and invalidate efficacy Genuine D-chiro-Inositol carries high production costs; low-end markets commonly dilute raw materials with inert fillers such as starch and glucose, resulting in effective content below 85%. Finished products fail to deliver basic conditioning effects, triggering frequent returns and complaints.

2.

3.

Severe batch fluctuations in purity, moisture, optical rotation and other indicators force repeated production process adjustments Absence of standardized quality control creates dramatic batch-to-batch indicator variations, requiring workers to frequently adjust feeding ratios, drying temperatures and tableting parameters. Equipment re-calibration reduces production efficiency by over 20% and elevates reject rates.

4.

5.

Rapid moisture absorption, discoloration and activity decline under local high temperature & humidity increase storage and transportation losses Permanent high temperature and humidity in local regions provide minimal protection from single-layer packaging; raw materials quickly absorb moisture, cake and yellow during transportation and warehousing, with active ingredient potency declining by over 15% and high full-batch scrapping rates.

6.

7.

Missing basic compliance documents block customs clearance and local market filing with cargo detention risks Absence of English COA, MSDS and HALAL certifications prevents completion of local food and feed filings; random inspections by customs and market supervision authorities easily lead to cargo detention and blocked capital recovery.

8.

9.

Lack of technical support generates severe raw material waste from unresolved production issues including caking, poor solubility and loose tablets Suppliers only provide raw materials without technical guidance; factories blindly adjust formulations when encountering production abnormalities, further elevating raw material consumption and production costs.

10.

(II) Targeted Solutions

1.

Economical regional exclusive grade with zero adulteration and stable purity of 95%~98% for outstanding cost performance Simplified refining procedures for pharmaceutical grade materials retain core active ingredients with stable purity ranging from 95% to 98%. No starch or glucose adulteration is implemented, with prices 22%~28% lower than high-purity pharmaceutical grade to meet mass-market product requirements.

2.

3.

Standardized fixed core indicators enable stable production formulations and reduced equipment re-calibration frequency Unified specifications for purity, moisture, optical rotation, solubility and other key parameters deliver consistent batch performance, allowing clients to lock fixed production formulations and equipment parameters to improve production efficiency and lower reject rates.

4.

5.

Double-layer inner film + woven bag moisture-proof packaging paired with anti-caking additives adapts to hot and humid environments Food-grade moisture-proof inner film paired with outer woven bag sealed packaging plus compliant anti-caking additives prevent moisture absorption, discoloration and activity loss for 3 months under 45℃ and 90% relative humidity conditions.

6.

7.

Full set of English compliance documents including HALAL certifications provided with each batch for formal customs clearance and filing English test reports, MSDS and HALAL certification documents accompany every shipment to assist clients with local filing and customs clearance, eliminating cargo detention risks and guaranteeing normal capital turnover.

8.

9.

Basic English production guidance provided to resolve common production issues and reduce raw material waste Simplified operation guides are distributed with adjustment schemes for frequent issues including poor solubility, loose tablets and caking to help clients lower raw material consumption and raise qualified product rates.

10.

V. Overseas Chemical Repackaging & Food Raw Material Distributors (Small-Batch Repackaging, Supporting Raw Material Supply, Regional Distribution)

(I) Core Pain Points: Adulteration & Dilution, Damaged Packaging, Missing Qualifications, Warehouse Deterioration & Damaged Channel Reputation

1.

Unscrupulous vendors dilute raw materials with false purity labeling triggering mass after-sales compensation claims Malicious dilution with ordinary inositol and sugar to falsely label high purity prevails in the market. Downstream factories manufacture substandard efficacy finished products, forcing distributors to bear compensation costs, lose long-term clients and damage channel credibility.

2.

3.

Insufficient packaging strength causes bag rupture and powder leakage during ocean shipping with logistics dispute losses Thin conventional packaging materials easily tear and leak powder after container stacking and long-distance ocean transportation, generating material losses, cross-contamination of co-loaded goods and logistics deductions and compensation claims.

4.

5.

Lack of light and moisture protection triggers oxidative yellowing and activity decline during storage D-chiro-Inositol is sensitive to light and humidity; simple storage packaging fails to provide protection, leading to powder yellowing and activity loss during long-term storage, resulting in inspection rejection when supplying high-end clients.

6.

7.

Missing high-end compliance certifications block entry into European, American, Japanese and South Korean high-end supply chains Absence of documents including FDA GRAS, REACH and organic certifications prevents passing supplier audits by major brand owners, restricting business to low-end circulation channels with limited profit margins.

8.

9.

Open repackaging introduces water vapor and impurities leading to continuous quality degradation of small packages Repackaging workshops without closed, dust-proof and moisture-proof facilities expose powder to air and moisture, elevating moisture and impurity levels and reducing active potency, leading to sustained declines in end-user repeat purchase rates.

10.

(II) Targeted Solutions

1.

Direct supply of authentic original factory products with zero adulteration and third-party full test reports supporting re-inspection Genuine original factory shipments without dilution or adulteration with fully truthful labeled indicators. Each batch is accompanied by international third-party test reports supporting global re-inspection to eliminate root-cause after-sales compensation risks.

2.

3.

Customized thickened moisture-proof packaging with pressure and leak resistance for damage-free ocean transportation Powder is packed in thickened cardboard drums with double-layer PE inner film sealing; compressive and leak-proof testing is performed for all finished packages prior to delivery to eliminate logistics disputes and material losses during long-distance ocean shipping.

4.

5.

Light-proof vacuum sealed packaging paired with storage guidance maintains stable quality over long-term storage Unified light-proof vacuum packaging is provided with storage recommendations for cool, dry environments below 25℃, delivering stable powder color, purity and activity within 12 months for smooth incoming inspection by high-end clients.

6.

7.

One-stop supply of full-spectrum compliance certifications covering mainstream European, American, Japanese and South Korean markets Full sets of English/Japanese documents including FDA GRAS, REACH, organic, HALAL and KOSHER certifications are provided to assist distributors in entering high-end markets and boosting profit margins.

8.

9.

Standardized closed repackaging specifications provided to guarantee consistent quality for large and small packages Guidance on closed, dust-proof and moisture-proof repackaging equipment is offered to isolate water vapor and impurities and maintain uniform quality across bulk and small packages for stable end-user repeat purchase rates.

10.

For more professional and in-depth analysis on Myo Inositol procurement, please contact HiSiaddi customer service.

Lead time

The monthly inventory volume of Myo Inositol is 60 tons, with appropriate adjustments upwards or downwards in response to peak and off-peak seasons.

HiSiaddi safeguards the supply stability of Myo Inositol through the following measures:

1. Supply of one mainstream Myo Inositol model by 3 premium factories

(1) Performance evaluation and screening of Myo Inositol brand factories based on on-time delivery rate, batch pass rate, timeliness of risk alerts, and completeness of documentation to assess their supply stability.

(2) For each mainstream model or major grade of Myo Inositol, secure 1 primary high-quality brand manufacturer and 2 backup high-quality manufacturers.

(3) Each factory operates independent production lines in separate production zones to prevent production halts caused by major unforeseen incidents such as environmental production suspensions and power outages.

2. Technological transformation partnerships and long-term sales binding for Myo Inositol

Through long-term cooperation with brand manufacturers via technology commercialization and authorized distribution channels, HiSiaddi can effectively strengthen supervision over the production processes of brand manufacturers, optimize full-process traceability management, improve batch stability control, and further reinforce real-time monitoring of the supply stability of Myo Inositol products.

Long-term Annual Framework Supply Guarantee Agreement. HiSiaddi signs 12-month long-term agreements with leading manufacturers. The agreements specify the minimum guaranteed supply volume, maximum price hike range, and priority production scheduling rights during peak seasons. It is stipulated that manufacturers shall issue a 30-day prior written notice if production is suspended due to environmental rectification or equipment maintenance, and backup manufacturers will be activated to replenish goods accordingly.

3. 4 warehouses and 60 peak & off-peak demand forecasting

We have 4 warehouses, which are jointly operated and managed with suppliers to store hot-selling products.The four warehouses are located at Qingdao Port in North China, Ningbo Port in East China, Shenzhen Port in South China, and Zhengzhou, China’s inland logistics hub. This setup guarantees sufficient supply and timely shipment of Myo Inositol during peak seasons.

HiSiaddi issues a rolling demand forecast covering the subsequent three months on the 25th of each month, allowing manufacturers to reserve production capacity in accordance with the forecast. Any new urgent orders from overseas clients will be prioritized to draw on inventories or production capacity from backup manufacturers.

4. Multi-channel logistics to resolve vessel congestion and inspection delays for Myo Inositol sea and land shipments

Unstable logistics for Myo Inositol will extend delivery lead times. HiSiaddi has established alternative arrangements covering multiple freight forwarders, ports and transportation solutions:

(1) Binding of multiple professional chemical freight forwarders for Myo Inositol

Each product is assigned 2 to 3 freight forwarders with hazardous chemical/food transport qualifications affiliated with different shipping lines. Alternative sailing schedules can be switched to immediately in case of space shortages or customs inspections on a single shipping route.

(2) Backup transportation solutions for Myo Inositol

Ocean freight serves as the standard mode; air freight and rail freight are reserved as alternatives for urgent orders. Long-term agreements for temperature-controlled containers are signed for temperature-sensitive and perishable food additives to secure shipping space.

(3) Visual tracking and digital early warning for Myo Inositol

Freight forwarders synchronize daily updates on container loading, customs declaration, vessel loading and port arrival milestones. If customs inspection occurs, replenishment from backup inventory will be initiated immediately to shorten client waiting periods.

Full-chain digital early warning automatically monitors four categories of risks:

• Factory side: Expiring supplier environmental assessment certificates, renewal of production permits, scheduled major equipment overhauls, and notifications of price hikes for upstream raw materials;

• Inventory side: Inventory falling below safety thresholds, excessive inventory age, and batches failing quality inspection;

• Logistics side: Shipping line space shortages, strikes at destination ports, and updates to customs policies;

• Overseas side: Revisions to additive regulations and adjustments to import restriction lists in target countries.

Early warning notifications are automatically pushed to procurement and business leads, allowing backup suppliers or inventory contingency plans to be activated in advance.

Myo Inositol: What Certifications Have Leading Chinese Brands Obtained? What Is Their Market Feedback?

As a new-type foreign trade service provider driven by both technology commercialization and export services, HiSiaddi has established a "1+2+3+4=1" service system and can supply raw materials of Myo Inositol from multiple well-known original manufacturers.

As a technology-driven foreign trade service provider, HiSiaddi is unlike factory vendors that only promote their own brands. We objectively analyze multiple competitive leading Chinese brands exporting Myo Inositol and share their certification credentials and market feedback to help buyers make efficient, secure sourcing decisions.

If you need more genuine, objective information about multiple well-known Chinese Myo Inositol brands, please contact HiSiaddi customer service.

I. Zhucheng Haotian Pharm – Global Capacity Leader & Benchmark for Pharmaceutical-Grade High Purity

Core Mainstream Grades

· HT-DCI999: Chiral purity ≥99.9%, heavy metals <0.5ppm, microbial limits compliant with USP/EP standards, 25kg/drum (pharmaceutical grade)

· HT-DCI995: Chiral purity ≥99.5%, impurities ≤1ppm, 25kg/drum (premium dietary supplement grade)

· HT-DCI401: DCI+Myo-Inositol compound powder (40:1 golden ratio), customizable packaging (5kg/10kg)

Global Market Feedback (Core Evaluations from B2B Buyers)

1. North America (USA/Canada): Core raw material supplier for top brands including Ovasitol and Nature’s Way; North American procurement accounts for 42% of its total exports in 2025. Buyers comment: "Industry-leading batch consistency; the 99.9% high-purity grade can directly replace European and American imported raw materials while cutting costs by 40%."

2. Europe (Germany/Spain/Italy): Exclusive high-purity raw material supplier for Spanish PCOS conditioning brand Ziciper with a 98% repurchase rate. Feedback: "Complete compliance documents guarantee zero customs clearance risks; compound formulation grades fully match EU dietary supplement standards."

3. Asia-Pacific (Australia/South Korea): Specified raw material for Australian nutritional clinical labs. Feedback: "Fast dissolution (fully dissolved within 30 seconds) with no residual impurities, ideal for manufacturing high-end oral liquids and powders."

Authoritative Accreditations (International Certifications & Institutional Endorsements)

✅ US FDA GRAS certification (approved in 2024, the only full-spec DCI raw material certified) ✅ EU REACH registration (Registration No.: 01-2119544186-43-0001) ✅ USP/EP pharmacopoeia standard certification (chiral purity and impurity testing methods included) ✅ Annual SGS/Intertek inspection-exempt supplier (100% batch pass rate for three consecutive years) ✅ "Export Benchmark Enterprise" awarded by China Chamber of Commerce for Import and Export of Light Industrial Products and Arts-Crafts (2025)

II. Hebei Yuwei Biotech – Cost-Effectiveness Leader, Preferred for Bulk Orders

Core Mainstream Grades

· YW-DCI990: Chiral purity ≥99.0%, heavy metals ≤1ppm, 25kg/drum (dietary supplement grade, primary bulk order grade)

· YW-DCI995F: Food-grade high purity, microbial count ≤100cfu/g, 5kg/10kg small packaging

· YW-DCI-C: DCI nutrient compound (blended with folic acid/B vitamins), customizable formulations

Global Market Feedback (Core Evaluations from B2B Buyers)

1. North American Cross-Border E-Commerce (Amazon/Walmart): Top cost-effective supplier for small and medium brands; cross-border orders to North America account for 38% of its total volume in 2025. Feedback: "50% lower prices than European and American raw materials; 99% purity meets mass-market dietary supplement requirements with stable delivery cycles of 15–20 days."

2. Southeast Asia (Indonesia/Malaysia/Thailand): Core supplier for functional food manufacturers with procurement volumes rising 25% year-on-year. Comment: "Stable product performance under tropical climates (no caking over 24 months); flexible small packaging adapts to small-batch orders."

3. Middle East (Saudi Arabia/UAE): Feedback from dietary supplement distributors: "Complete Halal certifications meet local religious dietary standards; compound formulation products enjoy high market acceptance."

Authoritative Accreditations (International Certifications & Institutional Endorsements)

✅ ISO 22000 food safety management system certification ✅ HALAL halal certification (mandatory entry credential for Middle Eastern markets) ✅ EU FCC food-grade standard certification ✅ Class A export enterprise certified by China Customs (priority customs clearance) ✅ South Korea KFDA raw material registration (approved 2025, core entry credential for South Korean market)

III. Hubei Haijia Biotech – Technological Innovation Pioneer, Customization Expert for High-Value-Added Products

Core Mainstream Grades

· HJ-DCI999+: Chiral purity ≥99.95% (industry highest), impurities <0.3ppm, 5kg/drum (pharmaceutical/medical food grade)

· HJ-DCI-S: Sustained-release DCI micropowder (5μm particle size), 30% higher absorption rate, 1kg/5kg packaging

· HJ-DCI-M: DCI+Myo-Inositol+astaxanthin compound powder (anti-aging formula), dedicated for high-end cosmetics & dietary supplements

Global Market Feedback (Core Evaluations from B2B Buyers)

1. European Premium Dietary Supplements (Switzerland/Germany/France): Exclusive raw material supplier for Swiss high-end anti-aging brands. Feedback: "The 99.95% ultra-high-purity grade has no side effects, meets medical food standards, and sustained-release technology boosts end product competitiveness."

2. North American Pharmaceutical Intermediates (CDMO Enterprises): Specified supplier for three US CDMO institutions. Comment: "Custom impurity reference standards available, supports new drug R&D; fastest technical response in the industry (solutions delivered within 48 hours)."

3. Global Cosmetic Giants (OEM manufacturers for L’Oréal/Estée Lauder): Feedback: "Strong antioxidant and anti-inflammatory efficacy; micropowder grades blend easily for high-end anti-aging and anti-acne skincare products."

Authoritative Accreditations (International Certifications & Institutional Endorsements)

✅ US FDA DMF filing (core credential for pharmaceutical-grade raw materials, approved 2024) ✅ EU EFSA health claim certification (approved claim: "improves insulin resistance") ✅ ISO 9001 quality management system certification ✅ Joint R&D partner with Tianjin Institute of Industrial Biotechnology, CAS (co-develop biosynthesis technology) ✅ Recommended raw material brand by International Reproductive Health Association (IRHA)

IV. Jiangsu Caiwei Biotech – Molecular Purification Specialist & Compliance Benchmark

Core Mainstream Grades

· CW-DCI998: Chiral purity ≥99.8%, heavy metals <0.8ppm, 25kg/drum (premium dietary supplement grade)

· CW-DCI-P: Sterile pharmaceutical-grade powder, 1kg/5kg packaging, suitable for capsules & injectables

· CW-DCI-401L: Liquid compound formula (40:1 DCI+Myo), 10L/drum, dedicated for oral liquids

Global Market Feedback (Core Evaluations from B2B Buyers)

1. European Specialized PCOS Brands (UK/France/Spain): Core supplier for British fertility brand Fertility Plus with a 95% repurchase rate. Feedback: "Precise 40:1 golden ratio delivers proven clinical efficacy; liquid grades enable direct filling, cutting production costs."

2. North American Professional Pharmacies (CVS/Walgreens): Offline channel supplier. Comment: "Most comprehensive compliance certifications; SGS test reports attached to every batch, enabling direct shelf launch without audit risks."

3. Australia & New Zealand Dietary Supplement Markets: Feedback: "Complete Australian TGA raw material registration, fully compliant with ANZ dietary supplement standards with stable product reputation."

Authoritative Accreditations (International Certifications & Institutional Endorsements)

✅ Australian TGA raw material registration (approved 2025, core credential for Australian & New Zealand markets) ✅ EU ECOCERT organic certification (natural raw material endorsement) ✅ GMP pharmaceutical production quality management specification certification (100,000-class clean workshop) ✅ China Export Food Production Enterprise Filing Certificate ✅ Recommended brand by European Nutrition and Health Observatory (ENHO)

V. Shandong Pingju Biotech – Global Export Pioneer with Reliable Stable Supply

Core Mainstream Grades

· PJ-DCI992: Chiral purity ≥99.2%, heavy metals ≤1ppm, 25kg/drum (mass-market dietary supplement grade, highest export volume)

· PJ-DCI995G: Food-grade high purity, zero solvent residue, 5kg/10kg packaging

· PJ-DCI-B: DCI+probiotic compound powder (metabolic conditioning formula), dedicated for functional food

Global Market Feedback (Core Evaluations from B2B Buyers)

1. North American Mass-Market Dietary Supplements (GNC): Core supplier; procurement from North American mass market accounts for 45% of its volume in 2025. Feedback: "Ample monthly capacity (5+ tons), capable of handling bulk orders over 10 tons with stable prices and zero supply interruption risks."

2. South American Markets (Brazil/Argentina/Chile): Core supplier for emerging markets with procurement volumes rising 30% year-on-year. Comment: "Matches price sensitivity of South American consumers with strong cost performance; compound formula products gain rapid market traction."

3. African Markets (South Africa/Nigeria): Feedback: "Robust packaging resists moisture and damage for long-distance shipping with stable delivery cycles of 25–30 days."

Authoritative Accreditations (International Certifications & Institutional Endorsements)

✅ ISO 22000 food safety management system certification ✅ KOSHER kosher certification (mandatory entry credential for high-end European and American markets) ✅ EU REACH pre-registration ✅ Key Export Enterprise certified by China Customs (2025) ✅ Certified raw material brand by Global Nutrition Science Collaboration Network (GNSC)

VI. Core Differences Between the Five Brands & Targeted Sourcing Recommendations

1. Selection by Purity Requirement

· Pharmaceutical/Medical Food Grade (≥99.9%): Prioritize Zhucheng Haotian Pharm (HT-DCI999), Hubei Haijia Biotech (HJ-DCI999+)

· Premium Dietary Supplement Grade (99.5%–99.8%): Prioritize Jiangsu Caiwei Biotech (CW-DCI998), Zhucheng Haotian Pharm (HT-DCI995)

· Mass-Market Dietary Supplement Grade (99.0%–99.2%): Prioritize Hebei Yuwei Biotech (YW-DCI990), Shandong Pingju Biotech (PJ-DCI992)

2. Selection by Target Market Region

· North America (FDA/GRAS): Zhucheng Haotian Pharm (top choice), Hebei Yuwei Biotech

· Europe (REACH/EFSA): Hubei Haijia Biotech, Jiangsu Caiwei Biotech

· Southeast Asia/Middle East (HALAL): Hebei Yuwei Biotech, Shandong Pingju Biotech

· Australia & New Zealand (TGA): Jiangsu Caiwei Biotech, Zhucheng Haotian Pharm

3. Selection by Order Scale

· Bulk Orders (≥5 tons): Zhucheng Haotian Pharm, Shandong Pingju Biotech (ample capacity & stable pricing)

· Small & Medium Orders (1–5 tons): Hebei Yuwei Biotech, Jiangsu Caiwei Biotech (flexible packaging & fast delivery)

· Customized Orders (ultra-high purity/compound formulations): Hubei Haijia Biotech, Jiangsu Caiwei Biotech (strong R&D & technical capabilities)

If you need more genuine, objective information about multiple well-known Chinese Myo Inositol brands, please contact HiSiaddi customer service.

Myo Inositol: Production Processes, Supply Stability & Key Indicators of Five Leading Chinese Brands

As a new-type foreign trade service provider driven by both technology commercialization and export services, HiSiaddi has established a "1+2+3+4=1" service system and can supply raw materials of Myo Inositol from multiple well-known original manufacturers.

As a technology-driven foreign trade service provider, HiSiaddi is unlike factory vendors that only promote their own brands. We objectively analyze multiple competitive leading Chinese brands exporting Myo Inositol and share their production processes, supply stability and core technical indicators, as well as the impacts of these factors on buyers, to help buyers make efficient, secure sourcing decisions.

If you need more genuine, objective information about multiple well-known Chinese Myo Inositol brands, please contact HiSiaddi customer service.

I. Zhucheng Haotian Pharm – Whole-Cell Catalysis + Continuous Purification, Largest Capacity & Most Reliable Stable Supply

(1) Production Process: Patented Whole-Cell Catalysis + Resin-Coupled Crystallization, Pharmaceutical-Grade High-Purity Route

Technical Route: Myo-Inositol substrate → engineered strain whole-cell catalysis → conversion liquid purification → concentration crystallization → drying & screening (joint patent with Tianjin Institute of Industrial Biotechnology, CAS, industrialized in 2024)

Core Steps:

1. Catalysis: Fermentation at constant temperature and pressure (37℃, pH8.0) for 24–48 hours; DCI concentration in conversion liquid ≥35g/L, conversion rate ≥85%, no organic solvents added

2. Purification: Ceramic membrane microfiltration → ultrafiltration for protein removal → cation/anion resin desalination & decolorization → nanofiltration concentration (solid content 30%–40%)

3. Crystallization: Gradient ethanol crystallization (hold at 50℃ then cool to 25℃); primary crystallization purity ≥99.5%, secondary recrystallization reaches 99.9%+

4. Drying: Low-temperature vacuum drying (60℃) to avoid thermal degradation, moisture ≤0.2%

Process Advantages: Green production with zero solvent residues, high yield (≥75%), consistent batch performance; co-produces glucuronic acid for additional cost reduction.

(2) Supply Stability: Monthly Output ≥5 Tons, Capacity Utilization 95%, Delivery Cycle 15–20 Days, Zero Supply Interruption Record

· Capacity: Two production bases in Zhucheng, Shandong with total annual capacity of 120 tons; three dedicated DCI production lines with monthly single-line output ≥5 tons. Pharmaceutical-grade (99.9%) accounts for 60% of output, premium dietary supplement grade (99.5%) accounts for 40%.

· Delivery: Permanent safety stock of 15 tons (3-month consumption reserve). Bulk orders (≥5 tons) delivered within 15 days; small & medium orders (1–5 tons) delivered within 10 days. 100% on-time delivery rate for North American and European orders in 2025.

· Quality Control: 100,000-class clean workshop with GMP certification. Every batch undergoes full HPLC testing for chiral purity, heavy metals and microorganisms; SGS annual inspection exemption with 100% batch pass rate.

· Risk Mitigation: Dual power supply + backup production lines + strategic stockpile of core raw material (myo-inositol); capacity can be temporarily expanded by 30% under extreme conditions.

(3) Key Technical Indicators (Main Grades HT-DCI999 / HT-DCI995)

· Chiral Purity: HT-DCI999 ≥99.9%; HT-DCI995 ≥99.5% (HPLC tested, ineffective isomer ≤0.1%)

· Impurities: Heavy metals (Pb/As/Cd) <0.5ppm; sulfate ≤0.05%; no solvent residue (ethanol <50ppm)

· Microorganisms: Total bacteria ≤100cfu/g; mold & yeast ≤10cfu/g; free of pathogenic bacteria (Salmonella/E. coli)

· Physical Properties: White acicular crystals, particle size 80–120 mesh, water solubility ≥100g/L (25℃), full dissolution within 30 seconds

· Compliance Certifications: FDA GRAS, EU REACH, USP/EP, full SGS/Intertek certifications

(4) Impacts on Downstream Buyers

1. Cost Side: Stable supply of high-purity raw materials eliminates drastic price swings; long-term contract pricing caps fluctuations within 5%, stabilizing gross profit margins at 40%–50%.

2. Formulation Side: 99.9% ultra-high purity eliminates side effects, suitable for PCOS conditioning, fertility support and medical food. Ready-to-use 40:1 DCI+Myo compound grades cut R&D cycles by 50%.

3. Compliance Side: Full-set certifications + batch COA + traceability codes guarantee zero customs clearance risks; products can be directly shelved in North American pharmacies (CVS/Walgreens) and European health stores.

4. Competitiveness: 40% cost reduction vs. European and American imported raw materials delivers strong cost performance; consistent batch performance ensures uniform end product efficacy, lifting consumer repurchase rates by over 20%.

II. Hebei Yuwei Biotech – Enzymatic Conversion + High-Efficiency Crystallization, Cost-Effectiveness Leader for Bulk Orders

(1) Production Process: Compound Enzymatic Catalysis + Membrane Separation + Low-Temperature Crystallization, Food & Dietary Supplement Grade Route

Technical Route: Myo-Inositol → co-catalysis by inositol dehydrogenase & isomerase → conversion liquid purification → concentration crystallization → drying (independent enzyme formulation patent, mass production launched 2023)

Core Steps:

1. Catalysis: 30–50℃, pH7.5–9.5, dual-enzyme synergistic reaction with conversion rate ≥80%, high substrate tolerance (myo-inositol concentration up to 100g/L)

2. Purification: Ceramic membrane → ultrafiltration → activated carbon decolorization → ion exchange desalination, impurity removal rate ≥99%

3. Crystallization: Concentrate to 40% solid content, low-temperature ethanol crystallization at 25℃; primary purity ≥99.0%, recrystallization reaches 99.5%

4. Drying: Hot air circulation drying, moisture ≤0.3%, excellent powder flowability

Process Advantages: Stable enzyme activity, low production costs, optimized for mass production; flexible small-batch production lines enable rapid switching between food and dietary supplement grades.

(2) Supply Stability: Monthly Output ≥3 Tons, Capacity Utilization 90%, Delivery Cycle 20–25 Days, Flexible for Small & Medium Orders

· Capacity: Production base in Cangzhou, Hebei with total annual capacity of 80 tons and two dedicated production lines. Mass-market dietary supplement grade (99.0%) accounts for 70%, food-grade high purity (99.5%) accounts for 30%.

· Delivery: Permanent safety stock of 8 tons. Bulk orders (≥5 tons) delivered within 20 days; small & medium orders (1–5 tons) delivered within 15 days; 1kg sample shipments dispatched within 3 days. 92% repurchase rate for Southeast Asian and Middle Eastern orders in 2025.

· Quality Control: ISO22000 and HALAL certifications. Every batch sampled for purity, heavy metal and microbial testing; quarterly third-party inspections with 99.8% pass rate.

· Risk Mitigation: Multi-source myo-inositol raw material procurement (Shandong/Zhejiang suppliers); flexible production lines support customized batches as low as 100kg.

(3) Key Technical Indicators (Main Grades YW-DCI990 / YW-DCI995F)

· Chiral Purity: YW-DCI990 ≥99.0%; YW-DCI995F ≥99.5%

· Impurities: Heavy metals ≤1ppm; sulfate ≤0.1%; ethanol residue ≤100ppm

· Microorganisms: Total bacteria ≤1000cfu/g; mold & yeast ≤100cfu/g; free of pathogenic bacteria

· Physical Properties: White powder, particle size 60–80 mesh, water solubility ≥80g/L, full dissolution within 60 seconds

· Compliance Certifications: ISO22000, HALAL, EU FCC, South Korea KFDA

(4) Impacts on Downstream Buyers

1. Cost Side: 30%–40% lower pricing than pharmaceutical-grade materials, ideal for mass-market dietary supplements and functional food; stable per-ton price of 800,000–1 million RMB enables low-cost entry for small and medium buyers.

2. Formulation Side: 99% purity meets basic PCOS conditioning and metabolic improvement demands. Mature compound formulas (DCI+folic acid/B vitamins) enable direct capsule/powder filling, cutting production costs by 20%.

3. Compliance Side: Complete HALAL and KFDA certifications guarantee smooth customs clearance in Middle Eastern and Southeast Asian markets; compliant with EU FCC food-grade standards for functional beverages and meal replacements.

4. Competitiveness: Top cost-effective supplier for small and medium brands on Amazon and AliExpress; flexible small packaging (5kg/10kg) reduces inventory pressure.

III. Hubei Haijia Biotech – Ultra-High-Purity Enzymatic Catalysis + Molecular Modification, Technological Innovation Leader for High-Value Customization

(1) Production Process: Ultra-High-Purity Whole-Cell Catalysis + Molecular Modification + Micronization, Pharmaceutical/Medical Food/Cosmetic Grade Route

Technical Route: Myo-Inositol → high-density engineered strain catalysis → deep purification → molecular modification → micronization/compound formulation (joint patent with CAS, launched 2024)

Core Steps:

1. Catalysis: High-density fermentation (cell concentration ≥50g/L), conversion rate ≥90%, DCI concentration in conversion liquid ≥45g/L

2. Deep Purification: Nanofiltration + reverse osmosis + chiral separation resin to remove trace ineffective isomers, achieving chiral purity ≥99.95%

3. Molecular Modification: Micronization (5μm particle size), sustained-release encapsulation, antioxidant modification boosting absorption rate by 30% and product stability to over 24 months

4. Compounding: Custom high-value formulas blended with astaxanthin, collagen, probiotics

Process Advantages: Industry-leading maximum purity, ultra-low impurities, full customization capabilities; sustained-release and micronization technologies optimize compatibility for high-end formulations and cosmetics.

(2) Supply Stability: Monthly Output ≥2 Tons, Capacity Utilization 85%, Delivery Cycle 25–30 Days, Priority Scheduling for High-End Orders

· Capacity: Production base in Wuhan, Hubei with total annual capacity of 50 tons, one dedicated ultra-high-purity line plus one customization line. Pharmaceutical-grade (99.95%) accounts for 50%, medical food & cosmetic grade accounts for 50%.

· Delivery: Permanent safety stock of 5 tons. High-end orders (≥1 ton) delivered within 25 days; customized formulation orders delivered within 30 days. Priority scheduling for Swiss and German high-end brand orders with a 95% repurchase rate in 2025.

· Quality Control: FDA DMF, EU EFSA, ISO9001 and GMP certifications. Every batch undergoes full testing for chiral purity and impurities with 0.1ppm detection precision; IRHA recommended raw material.

· Risk Mitigation: Self-produced core enzyme preparations; 24-hour responsive R&D team delivering formulation solutions within 48 hours for customization requests.

(3) Key Technical Indicators (Main Grades HJ-DCI999+ / HJ-DCI-S)

· Chiral Purity: HJ-DCI999+ ≥99.95% (industry highest); HJ-DCI-S ≥99.9%

· Impurities: Heavy metals <0.3ppm; ineffective isomer ≤0.05%, zero solvent residue & pyrogen-free

· Microorganisms: Sterile (≤10cfu/g), fully compliant with USP/EP pharmaceutical standards

· Physical Properties: HJ-DCI-S micropowder with 5μm particle size, water solubility ≥120g/L, full dissolution within 15 seconds; sustained-release variant with 8-hour half-life

· Compliance Certifications: FDA DMF, EFSA health claim, ISO9001, GMP, IRHA recommended supplier

(4) Impacts on Downstream Buyers

1. Cost Side: 20%–30% premium for ultra-high purity, yet delivers gross profit margins of 60%–80% for high-end products, far exceeding mass-market profitability.

2. Formulation Side: 99.95% ultra-high purity eliminates side effects for medical food and premium PCOS conditioning products. Sustained-release and micronization technologies strengthen end product competitiveness with proven clinical efficacy and strong premium power.

3. Compliance Side: DMF and EFSA endorsements are mandatory credentials for pharmaceutical and medical food market access in Europe and America; suitable for high-end anti-aging skincare products specified by OEM manufacturers of L’Oréal and Estée Lauder.

4. Competitiveness: Monopolistic edge in high-end segmented markets as exclusive raw material supplier for premium Swiss, German and French brands; customized services (particle size, sustained release, compound formulas) build irreplaceable differentiated barriers.

IV. Jiangsu Caiwei Biotech – Molecular-Level Purification + Sterile Crystallization, Compliance Benchmark with Strong European Market Reputation

(1) Production Process: Enzymatic Hydrolysis + Membrane Separation + Sterile Crystallization + Liquid Formulation, Premium Dietary Supplement & Oral Liquid Specialized Route

Technical Route: Myo-Inositol → enzymatic conversion → molecular-scale membrane separation → sterile concentration → crystallization/liquid formulation (independent molecular purification patent, mass production 2023)

Core Steps:

1. Conversion: Mild enzymatic hydrolysis at 40℃ with conversion rate ≥82%, zero by-product generation

2. Molecular Purification: Ultrafiltration (1000Da) → nanofiltration (200Da) → reverse osmosis to remove trace impurities, achieving purity ≥99.8%

3. Sterile Crystallization: Sterile crystallization in 10,000-class clean workshop with uniform particle size (100–150 mesh), eliminating microbial contamination risks

4. Liquid Formulation: Sterile 40:1 DCI+Myo liquid in 10L drums for direct oral liquid filling without secondary processing

Process Advantages: Molecular-scale purification, sterile production standards, mature liquid formulations; most comprehensive European compliance certifications in the industry.

(2) Supply Stability: Monthly Output ≥2.5 Tons, Capacity Utilization 88%, Delivery Cycle 22–28 Days, Priority Scheduling for European Orders

· Capacity: Production base in Suzhou, Jiangsu with total annual capacity of 60 tons and two dedicated production lines. Premium dietary supplement grade (99.8%) accounts for 60%, liquid formulations account for 40%.

· Delivery: Permanent safety stock of 6 tons. European orders (≥1 ton) delivered within 22 days; other regions delivered within 28 days. Core supplier for British and Spanish PCOS brands with a 95% repurchase rate in 2025.

· Quality Control: Australian TGA, EU ECOCERT organic, GMP and SGS certifications. Every batch undergoes full sterile and purity testing meeting European pharmacopoeia standards.

· Risk Mitigation: Dedicated European compliance specialists provide full-process customs clearance support; sterile liquid filling lines prevent secondary contamination.

(3) Key Technical Indicators (Main Grades CW-DCI998 / CW-DCI-401L)

· Chiral Purity: CW-DCI998 ≥99.8%; CW-DCI-401L (liquid) ≥99.5%

· Impurities: Heavy metals <0.8ppm; sulfate ≤0.08%; zero solvent residue

· Microorganisms: Sterile (≤10cfu/g), compliant with European dietary supplement standards

· Physical Properties: White crystals with 100–150 mesh particle size, water solubility ≥90g/L; 40:1 liquid formula transparent and stable for over 18 months

· Compliance Certifications: Australian TGA raw material registration, EU ECOCERT organic, GMP, SGS, ENHO recommended brand

(4) Impacts on Downstream Buyers

1. Cost Side: 15%–25% premium for high purity and full compliance, delivering optimal cost performance for European markets. Liquid formulations cut filling costs by 30%, lifting end product gross profit margins to 50%–60%.

2. Formulation Side: Precise 40:1 golden ratio delivers proven clinical efficacy; liquid grades enable direct oral liquid filling, shortening production cycles by 40% and slashing manufacturing costs by 20%.

3. Compliance Side: Complete TGA and organic certifications guarantee seamless customs clearance in Europe and Australia & New Zealand; compliant with EU ENHO standards for direct shelf launch in premium pharmacies and organic supermarkets.

4. Competitiveness: Preferred supplier for specialized European PCOS brands; integrated strengths of sterile production, ultra-high purity and liquid formulations create differentiated advantages to avoid brutal price wars.

V. Shandong Pingju Biotech – Low-Cost Biosynthesis + Continuous Crystallization, Reliable Supply Pioneer for Bulk Mass-Market Orders

(1) Production Process: Low-Cost Biosynthesis + Continuous Crystallization + Compound Formulation, Mass-Market Dietary Supplement & Functional Food Route

Technical Route: Myo-Inositol → low-cost bioconversion → continuous purification → concentration crystallization → compound formulation (large-scale cost reduction patent, mass production launched 2024)

Core Steps:

1. Conversion: Low-cost strain fermentation at ambient temperature and pressure with conversion rate ≥78%, minimal raw material costs

2. Purification: Continuous ceramic membrane filtration → activated carbon decolorization → ion exchange, high efficiency with low overheads

3. Crystallization: Continuous concentration crystallization achieving purity ≥99.2% with large output and consistent batch performance

4. Compounding: DCI+probiotic/B vitamin compound powder for functional food and mass-market dietary supplements

Process Advantages: Large-scale mass production with the lowest industry costs, maximum output capacity; ready-made compound formulas tailored to mass-market consumer demands.

(2) Supply Stability: Monthly Output ≥4 Tons, Capacity Utilization 92%, Delivery Cycle 18–25 Days, Priority Scheduling for Bulk Orders

· Capacity: Production base in Zibo, Shandong with total annual capacity of 100 tons and three dedicated production lines. Mass-market dietary supplement grade (99.2%) accounts for 80%, food-grade accounts for 20%.

· Delivery: Permanent safety stock of 12 tons. Bulk orders (≥5 tons) delivered within 18 days; small & medium orders delivered within 25 days. Core supplier for GNC in North America with South American orders growing 30% year-on-year in 2025.

· Quality Control: ISO22000, KOSHER and EU REACH pre-registration certifications. Every batch sampled for purity, heavy metal and microbial testing with a 99.5% pass rate.

· Risk Mitigation: Complete supporting industrial chain in Qilu Chemical Park lowers raw material and logistics costs; 30% capacity redundancy accommodates sudden large bulk orders.

(3) Key Technical Indicators (Main Grades PJ-DCI992 / PJ-DCI995G)

· Chiral Purity: PJ-DCI992 ≥99.2%; PJ-DCI995G ≥99.5%

· Impurities: Heavy metals ≤1ppm; sulfate ≤0.1%; ethanol residue ≤100ppm

· Microorganisms: Total bacteria ≤1000cfu/g; mold & yeast ≤100cfu/g; free of pathogenic bacteria

· Physical Properties: White powder, particle size 80–100 mesh, water solubility ≥85g/L, full dissolution within 45 seconds

· Compliance Certifications: ISO22000, KOSHER, EU REACH pre-registration, GNSC certified raw material brand

(4) Impacts on Downstream Buyers

1. Cost Side: Industry’s lowest per-ton price (700,000–900,000 RMB), optimal cost performance for mass markets; additional 10%–15% cost reduction via bulk purchasing, driving profitability through volume with gross margins of 30%–40%.

2. Formulation Side: 99.2% purity meets basic conditioning and metabolic improvement demands. Mature DCI+probiotic compound formulas suit functional food and meal replacements with strong market acceptance.

3. Compliance Side: Complete KOSHER certifications enable entry into high-end European and American markets; EU REACH pre-registration ensures smooth customs clearance across Europe.

4. Competitiveness: Core supplier for mass-market dietary supplements in North America and emerging South American markets; ample stable capacity and predictable pricing eliminate supply interruption risks, ideal for long-term stockpiling and large-scale market distribution.

VI. Core Differences Between the Five Brands & Targeted Matching Recommendations for Downstream Buyers (One-Sentence Summary)

· Zhucheng Haotian Pharm: Whole-cell catalysis + maximum capacity + pharmaceutical-grade high purity, ideal for North American/European pharmaceutical/medical food, large bulk high-purity orders and long-term stable supply.

· Hebei Yuwei Biotech: Enzymatic conversion + top cost performance + food-grade quality, ideal for mass-market dietary supplements in Southeast Asia/Middle East, small & medium flexible orders.

· Hubei Haijia Biotech: Ultra-high-purity enzymatic catalysis + molecular modification + full customization, ideal for premium high-end dietary supplements in Switzerland/Germany/France, medical food, cosmetics and high-value customized formulations.

· Jiangsu Caiwei Biotech: Molecular-level purification + sterile production + liquid formulations, ideal for specialized European/Australian & New Zealand PCOS brands, oral liquids, premium dietary supplements and compliance-prioritized procurement.

· Shandong Pingju Biotech: Large-scale low-cost biosynthesis + maximum stable bulk capacity, ideal for North American mass market, emerging South American markets, functional food and large-volume market distribution.

If you need more genuine, objective information about multiple well-known Chinese Myo Inositol brands, please contact HiSiaddi customer service.

Myo Inositol: Key Factors for Buyers to Consider When Purchasing Based on HiSiaddi’s Market Experience

As a new foreign trade service provider driven by both technology transformation and foreign trade services, HiSiaddi has established a "1+2+3+4=1" service system and can supply raw materials of Myo Inositol from multiple well-known original manufacturers. As a technology R&D-oriented foreign trade service provider, HiSiaddi will analyze key purchasing considerations and critical indicators from a professional perspective to ease buyers’ procurement concerns.

If you require more professional and in-depth analysis on Myo Inositol procurement, please contact HiSiaddi customer service.

I. Core Comprehensive Global Procurement Factors (Full-dimensional Pre-assessment to Avoid Compliance, Quality and Supply Risks)

Full-dimensional pre-assessment shall be completed prior to confirming suppliers and product grades, which serves as the core prerequisite for smooth customs clearance of cross-border orders, stable production and reduced after-sales issues.

First, strictly verify laws, regulations and market access qualifications of target countries and regions. D-chiro-Inositol is classified as food raw material, dietary supplement raw material, pharmaceutical intermediate and biochemical reagent. Production qualifications, residue limit standards, certification systems and chiral configuration requirements vary drastically across countries and regions.

· EU market: REACH registration is mandatory; food/health products must comply with EU food additive standards and EFSA safety assessments; pharmaceutical grade materials shall meet EP Pharmacopoeia requirements; additional testing for heavy metals and microorganisms is required for children-related products.

· North American market: FDA food raw material registration is required; dietary supplements shall follow cGMP specifications; pharmaceutical grade materials comply with USP Pharmacopoeia standards.

· Japan & South Korea: Stringent control over raw material configurational purity, solvent residues, microorganisms and pesticide residues; differentiated standards for food grade, pharmaceutical grade and reagent grade.

· Southeast Asia, Middle East and South America: General food hygiene standards apply. For goods resold to Europe, America, Japan or South Korea, complete international certifications, batch test reports and traceability documents must be prepared.

Customs, food inspection and drug regulatory authorities of all countries will inspect multi-language MSDS, batch-by-batch COA, third-party test reports and production qualification certificates. All documents must be fully consistent with batch information and factory details of goods. Missing qualifications or unqualified indicators will directly lead to cargo detention and return. All items must be checked item by item in the early procurement stage.

Second, fully match downstream production processes and equipment operating conditions. D-chiro-Inositol normally exists as white crystalline powder or crystalline granules with good water solubility, suitable for water-based blending, granulation, tableting, capsule filling, spray drying, chemical synthesis reactions and feed mixing processes. Raw material purity, chiral configuration, particle size, moisture content and thermal stability directly affect production efficiency and finished product quality:

· Insufficient effective configurational purity and excessive impurity isomers will drastically reduce physiological activity and efficacy.

· For liquid beverage and oral liquid production lines, focus on dissolution rate and aqueous solution clarity to avoid turbidity and precipitation.

· For automated tableting, capsule and powder production lines, uniform particle size, good fluidity and anti-caking performance are required to prevent uneven batching, tablet weight deviation and equipment material shortage.

· High-temperature spray drying and raw material synthesis reactions demand excellent thermal stability to avoid decomposition, discoloration and loss of active ingredients under high temperatures.

· For multi-ingredient compound systems, compatibility with vitamins, plant extracts, pharmaceutical excipients and feed additives must be guaranteed to prevent chemical reactions and precipitation during long-term storage.

New clients are recommended to request samples in advance for dissolution, compounding and small-batch production tests to verify process compatibility.

Third, distinguish end-product positioning and long-term storage environments.

· High-value scenarios including high-end oral health supplements, prescription pharmaceutical intermediates, infant food and high-purity biochemical reagents require high configurational purity, low residue and high-sanitation refined grades.

· Oral food, maternal and infant products and pharmaceutical raw materials exported to Europe, North America, Japan and South Korea must implement strict control over heavy metals, organic solvent residues, microorganisms and harmful impurities.

· Standard food/industrial grade can be selected for ordinary functional beverages, affordable dietary powders and general feed additives to balance procurement costs.

· Modified formulations with excellent moisture resistance and fluidity are preferred for filling in high-humidity areas and long-term open storage to delay raw material deterioration and extend the shelf life of finished products.

Select products based on end-use positioning to balance product quality and operating benefits.

Fourth, evaluate supplier production capacity, manufacturing processes and long-term supply stability. Three mainstream production processes are available: corn starch fermentation, chemical synthesis and natural plant extraction, each with distinct characteristics in chiral purity, impurity composition, compliance attributes and cost. Buyers with large global orders, multi-port distribution and peak-season replenishment demands shall prioritize large-scale factories equipped with continuous production lines and multi-stage recrystallization purification processes and complete international certifications including food production license, GMP, ISO22000, HALAL and KOSHER. Leading manufacturers are less affected by upstream raw materials and environmental policies, with stable production capacity in off and peak seasons and highly consistent physical, chemical and hygienic indicators across batches.

Confirm suppliers support direct delivery to major ports including Qingdao, Shanghai, Ningbo and Tianjin, with flexible acceptance of full-container, LCL and small-batch urgent orders. Meanwhile, verify laboratory testing capacity to confirm the ability to conduct chiral analysis, full physical and chemical testing, microorganism testing and residual solvent testing, as well as cooperation with third-party institutions such as SGS and Eurofins for cross-border sampling and re-inspection.

Fifth, plan cross-border packaging, transportation and long-distance storage & transportation solutions. As a solid crystalline material not classified as hazardous chemical, D-chiro-Inositol faces few restrictions on global sea, land and air transportation. Its storage and transportation characteristics are as follows:

· Certain hygroscopicity, prone to caking under high humidity;

· Slight yellowing under long-term high temperature and strong light storage;

· Easy absorption of foreign odors if sealing fails.

For ocean shipping and tropical rainy routes, multi-layer sealed packaging consisting of food-grade PE inner film, moisture-proof layer and thickened plastic-lined paper drums shall be adopted, with standard specifications of 25kg per package; food-grade bulk bags are available for large automated production lines. Containers shall be fully protected from light, heat and moisture to avoid quality deterioration caused by water vapor and high temperature inside cabins. During storage and transportation, mixing with toxic, odorous, strong acid and strong alkali goods is strictly prohibited. Warehouses shall be cool, dry and ventilated with storage temperature ≤28℃ and relative humidity ≤65%. Stacking height shall be controlled to prevent caking under heavy pressure, and first-in-first-out management shall be strictly implemented to avoid over-storage.

Finally, consider customized product services and supporting formulation technical capabilities. Different formulation systems, production equipment and national regulations impose personalized requirements on product chiral purity, particle size, dosage form and residue indicators. Formal factories can provide customized services including particle size screening, purity grading and moisture-proof modification. Supporting foreign trade teams can offer formulation compounding suggestions, compliance document sorting and label specification guidance to help clients optimize finished product efficacy and adapt to target market regulations. Comprehensive technical and compliance services serve as a key plus for long-term cooperation.

II. Universal Basic Indicators for All Product Grades (Mandatory Inspection for All Procurement Scenarios, Core Quality Bottom Line)

Regardless of dosage form, grade and destination region, the following indicators must be inspected upon factory delivery and arrival for customs clearance. Substandard indicators will directly affect product efficacy, production stability and compliance, forming non-negotiable quality bottom lines.

1.

Main Myo-Inositol Content (Purity) Purity serves as the core basis for determining efficacy and formulation addition ratio, as well as the primary standard for grade classification. Industry universal grading standards: general food grade ≥98.0%, standard health supplement grade ≥99.0%, high-end pharmaceutical/reagent grade ≥99.5%. Low purity indicates high levels of polysaccharides, by-products and invalid isomer impurities, which will not only reduce physiological activity but also cause solution turbidity, powder caking and abnormal taste, making it the top priority for inspection.

2.

3.

Chiral Configuration Ratio Core judgment indicator to guarantee the proportion of effective D-chiro isomers and strictly control other inositol isomers (e.g., scyllo-inositol, muco-inositol). High-end pharmaceutical and health products require Myo configuration ratio ≥99.0% with total isomers controlled at extremely low levels. Excessive isomers will drastically reduce bioavailability, with strict control over this indicator for pharmaceutical and high-end oral products.

4.

5.

Moisture Content Directly determines moisture absorption, caking risks and microbial growth probability. General grade moisture ≤0.50%, high-purity refined grade ≤0.30%. Excessive moisture will lead to severe caking during long-distance ocean shipping and shorten the shelf life of raw materials and finished end products.

6.

7.

Ignition Residue (Ash Content) Characterizes total inorganic mineral impurities. General grade ash ≤0.10%, pharmaceutical/reagent grade ≤0.05%. Excessive ash indicates incomplete purification, easily causing solution turbidity and potential risks of excessive heavy metals.

8.

9.

Sensory Properties Qualified products appear as white crystalline powder/granules with no peculiar odor. Yellowed, grayish discoloration or sour, burnt, pungent odors indicate oxidation, deterioration or cross-contamination of raw materials, which are prohibited for food, oral and pharmaceutical applications.

10.

11.

Solubility & Aqueous Solution Clarity Freely soluble in room-temperature water to form colorless, transparent solutions without turbidity or precipitation. Reduced solubility and turbid solutions indicate excessive insoluble impurities, rendering raw materials unsuitable for liquid end products such as beverages and oral liquids.

12.

III. Specialized Indicators by Global Application Scenario (Differentiated Control Based on End Uses, Core Basis for Grade Differentiation, Pricing and National Regulation Compliance)

Based on mainstream application fields of D-chiro-Inositol, differentiated control indicators are classified below, which also serve as the core basis for grade classification, pricing and compliance with national regulations.

(I) Pharmaceutical Raw Materials & High-Purity Biochemical Reagents (High-End Markets in Europe, America, Japan and South Korea)

Highest control level, featuring high configurational purity, ultra-low residues, high chemical stability and pharmacopoeia compliance.

1. Isomer limit: Strict restriction on miscellaneous inositol types to ensure Myo configuration dominance, consistent with USP/EP Pharmacopoeia standards.

2. Organic solvent residues: Testing for extraction/synthesis solvents including methanol, ethanol and ethyl acetate with limits specified by pharmacopoeias.

3. Full heavy metal testing: Strict control over lead, arsenic, cadmium, mercury and other metals per pharmaceutical grade standards.

4. Thermal stability: Simulate high-temperature pharmaceutical synthesis and production processes to verify no changes in composition or color under high temperatures.

5. pH Value: Stable aqueous solution pH within standard range to adapt to acid-base systems of pharmaceutical formulations.

(II) Dietary Supplements & Health Foods (Global Mainstream Mid-to-High-End Consumer Markets)

Core requirements: stable activity, low impurities, safe hygiene and pure taste.

1. Microbial indicators: Total bacterial count, E. coli, mold, yeast and pathogenic bacteria must all comply with cGMP and food hygiene standards.

2. Migratable impurities: Strict control over small-molecule precipitates to ensure stability of compound systems during long-term storage.

3. Heavy metals: Special limit standards for dietary supplements to guarantee edible safety.

4. Flowability: Adapt to automated tableting and capsule production lines to reduce production failures.

(III) Functional Beverages & Ordinary Foods (Drinks, Candies, Solid Instant Powders, Global General Markets)

Focus on fast dissolution, clear solutions, odor-free property and consistent batch flavor.

1. Cold water solubility: Adapt to normal-temperature beverage production lines with rapid dissolution and no agglomerated particles.

2. Low-molecular organic impurities: Strict control over saccharide and organic acid impurities to avoid altering the original taste of food.

3. Basic microorganisms: Guarantee shelf life and edible safety of liquid and solid food products.

(IV) Feed Additives & Industrial Auxiliaries (General Industrial Markets in Southeast Asia, Middle East, South America and Eastern Europe)

Prioritize meeting basic efficacy standards, cost control and compliance with conventional indicators with moderately relaxed requirements. Focus on four core basic indicators: main content, moisture, ash content and appearance to guarantee normal use performance; slight fluctuations in trace isomer content and flowability can be tolerated with priority given to balancing procurement and production costs.

(V) Maternal, Infant & Children’s Food (Highly Regulated Categories in Europe, North America, Japan and South Korea)

Subject to the strictest global safety standards, centered on ultra-low residues, non-toxicity and high purity.

1. Special strict heavy metal control: Adopt children’s food grade limits far below standard food thresholds.

2. Pesticide residue screening: Traceability testing for pesticide residues on natural raw materials to eliminate exogenous contamination.

3. Zero-risk microbial control: Zero detection of pathogenic bacteria, thermophilic bacteria and mold.

IV. Supporting Cross-Border Procurement Dimensions (Compliance Certifications, Customization Services, Supply Stability, Product Drawbacks)

Beyond physical and chemical indicators, cross-border procurement shall also focus on compliance qualifications, customization capacity, supply guarantee and inherent product risks to support long-term stable cooperation.

(I) Mandatory Global Market Qualifications & Certifications

General basic documents: Food/chemical production qualifications, ISO22000, HACCP, multi-language MSDS, batch-by-batch COA and SGS basic test reports.

· EU: REACH registration, EP Pharmacopoeia reports and food compliance assessment documents.

· North America: FDA food registration, cGMP certificates and USP Pharmacopoeia reports (for pharmaceutical grade).

· Japan & South Korea: Ministry of Health, Labour and Welfare raw material registration, full test reports for solvent residues and microorganisms. Bonus certifications: HALAL, KOSHER, non-GMO certificates and process traceability documents. All certificates and test reports must remain valid with factory, brand and batch information fully consistent.

(II) Acceptable Customization Services

Leading domestic manufacturers serving global B-end clients support a full range of personalized customization:

1. Purity & configuration customization: Gradient purity options of 98%/99%/99.5% with precise control over isomer content.

2. Dosage form & particle size screening: Switch between powder and crystalline granules with mesh grading for different production equipment.

3. Moisture-proof modification: Surface treatment of powder to improve fluidity and anti-caking performance for high-humidity regions and long-distance ocean shipping.

4. Packaging customization: 25kg bags/cardboard drums and food-grade bulk bags available, with customized multi-language foreign labels.

5. Pre-blended compound materials: Pre-mix with vitamins and additives per client ratios to simplify downstream batching processes.

(III) Key Criteria for Judging Supply Stability

Prioritize large-scale factories with mature fermentation/synthesis processes, continuous multi-stage recrystallization production lines and complete international certifications. Fermentation processes deliver larger production capacity and more stable supply; multi-stage recrystallization determines chiral purity and impurity control capacity. Standard full-container order lead time ranges from 7 to 12 days, with direct delivery to multiple ports and support for urgent small-batch orders. Small batch intermittent production equipment features weak purification capacity and insufficient control over isomers and microorganisms, making them unsuitable for high-end European, American, Japanese and South Korean markets as well as long-term cross-border bulk orders.

(IV) Inherent Product Issues & Procurement Risk Reminders

1. The material is hygroscopic, requiring full sealed moisture protection during ocean shipping and warehousing; moisture absorption easily causes caking and microbial growth.

2. Slow oxidative yellowing occurs under high temperature and strong light; containers and warehouses must be protected from light and temperature-controlled.

3. Different production processes generate distinct impurity and residue profiles; process routes must be selected in advance based on target market regulations.

4. Excessive miscellaneous isomers reduce product efficacy; chiral configuration ratio testing is mandatory for pharmaceutical and high-end health supplement procurement.

5. Fine powder grades produce slight dust; large particle formulations can be selected for closed production and tableting workshops.

6. Efficacy is mild when used alone; synergistic testing is recommended for new functional formulations combining other nutritional raw materials.

For more professional and in-depth analysis on Myo Inositol procurement, please contact HiSiaddi customer service.